ASX-Dividend-Report-Banner

Lunit Expands Partnership with Saudi Arabia's Largest Medical Group to Deploy AI Chest X-Ray Solution

March 07, 2025 01:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Lunit Expands Partnership with Saudi Arabia's Largest Medical Group to Deploy AI Chest X-Ray Solution
Image source: Kalkine Media

Following last year's success, Lunit secures a second contract with Dr. Sulaiman Al Habib Medical Group, analyzing 1 million chest X-rays over three years

SEOUL, South Korea, March 6, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a second agreement with Cloud Solutions, a subsidiary of Dr. Sulaiman Al Habib Medical Group (HMG), Saudi Arabia's largest medical organization. Building on the success of their 2023 collaboration, Lunit will now supply its AI-powered chest X-ray analysis solution, Lunit INSIGHT CXR, to the Kingdom of Saudi Arabia for the next three years, analyzing approximately 1 million chest X-ray images.


 

Lunit and HMG representatives at ECR 2025. From left: Abdelrahman Elgammal, EMEA Customer Success Manager, Lunit; Abdulaziz Muawwadh, Cloud Solutions IT RIS&PACS Implementation Manager, HMG; Teri Thomas, Chief Business Officer, Lunit; and Jaemin Oh, EMEA General Manager, Lunit. (Photo: Lunit)
Lunit and HMG representatives at ECR 2025. From left: Abdelrahman Elgammal, EMEA Customer Success Manager, Lunit; Abdulaziz Muawwadh, Cloud Solutions IT RIS&PACS Implementation Manager, HMG; Teri Thomas, Chief Business Officer, Lunit; and Jaemin Oh, EMEA General Manager, Lunit. (Photo: Lunit)

This latest contract expands on Lunit's initial partnership with HMG, which introduced Lunit INSIGHT MMG to support breast cancer screening across the Kingdom. With Lunit INSIGHT CXR, the collaboration aims to enhance diagnostic precision and efficiency in detecting critical chest abnormalities, including lung cancer, tuberculosis, and pneumonia.

"We are proud to further strengthen our collaboration with Dr. Sulaiman Al Habib Medical Group," said Brandon Suh, CEO of Lunit. "This second contract underscores the value of our AI solutions and reflects our shared commitment to advancing healthcare through innovation."

Revolutionizing Diagnostics with AI

Lunit INSIGHT CXR leverages advanced AI technology to detect chest abnormalities with high accuracy, enabling faster, more precise diagnoses and optimized clinical workflows. Its deployment aligns with Saudi Arabia's Vision 2030 initiative, which emphasizes healthcare innovation and digital transformation.

Driving Regional Growth in AI Healthcare

According to Markets and Data, Saudi Arabia's AI in medical diagnostics market is projected to witness a compound annual growth rate (CAGR) of 26.97%, growing from USD 34.37 million in 2023 to USD 231.77 million by 2031. This second contract strengthens Lunit's foothold in a region poised for rapid adoption of AI-powered healthcare solutions.

"Expanding our partnership with HMG demonstrates the growing demand for AI-powered diagnostics across the Middle East," added Suh. "We are excited to continue supporting Saudi Arabia's healthcare transformation while addressing key challenges such as radiologist shortages."

###

About Lunit

Founded in 2013, Lunit (KRX:328130.KQ) is a medical AI company on a mission to conquer cancer through AI. Lunit harnesses AI-powered medical image analytics and biomarker analysis to ensure accurate diagnosis and optimal treatment for each cancer patient. The FDA-cleared Lunit INSIGHT suite for cancer screening serves over 4,800 medical institutions across 55+ countries. Lunit clinical studies have been published in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. Headquartered in Seoul, South Korea, with a network of offices worldwide, Lunit leads the global fight against cancer. Discover more at lunit.io.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.